A 3-in-1 vaccine is being reported that could potentially protect against flu, COVID, and RSV. The vaccine's development and potential impact on immunization rates are being discussed, particularly in the context of the upcoming respiratory virus season. However, it is unclear if this vaccine has been approved or released, as some outlets are still providing general guidance on existing COVID, flu, and RSV vaccines.